Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0001415889-25-021027

Options or other derivatives

  • Chief Business Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McKinley Kate Chief Business Officer 2025-08-01 Grant or award · Employee Stock Option (Right to Buy) +120,000 120,000 D
Loading xslF345X05/form4-08052025_080849.xml…